Good outcome in HIV-infected refugees after resettlement in New Zealand: Population study

Internal Medicine Journal

Volumn 37, Issue 5, 2007, Pages 290-294

  Nisbet, S M ^a   Reeve, A M ^b   Ellis Pegler, R B ^a   Woodhouse, A F ^a   Ingram, R J ^a   Roberts, S A ^a   McAllister, S M ^c   Thomas, M G ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b Mangere Refugee Resettlement Centre   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

HIV; New Zealand; Refugee

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMIGRATION; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; POPULATION RESEARCH; PRIORITY JOURNAL; REFUGEE; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; EMIGRATION AND IMMIGRATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEW ZEALAND; REFUGEES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34248351070     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01335.x     Document Type: Article

References (19)

1. Harris M, Telfer B. The health needs of asylum seekers living in the community. Med J Aust 2001 175: 589 92.
2. Burnett A, Peel M. Asylum seekers and refugees in Britain: health needs of asylum seekers and refugees. BMJ 2001 322: 544 7.
3. Murphy A, Lynch M, Bury G. 'Cead Mile Failte' - an assessment of the screening of 178 Bosnian refugees to Ireland. Ir Med J 1994 87: 174 5.
4. Ackerman L. Health problems of refugees. J Am Board Fam Pract 1997 10: 37 48.
5. Gavagan T, Brodyaga L. Medical care for immigrants and refugees. Am Fam Physician 1998 57: 1061 8.
6. Carey J, Duke K, Karn V, Marshall T. The Settlement of Refugees in Britain. Home Office Research Study 141. London: HMSO 1995.
7. Zuber P, Knowles L, Binkin N, Tipple M, Davidson P. Tuberculosis among foreign-born persons in Los Angeles County, 1992-1994. Tuber Lung Dis 1996 77: 524 30.
8. DeRiemer K, Chin D, Schecter G, Reingold A. Tuberculosis among immigrants and refugees. Arch Intern Med 1998 158: 753 60.
9. Slutsker L, Tipple M, Keane V, McCance C, Campbell C. Malaria in east African refugees resettling to the United States: development of strategies to reduce risk of imported malaria. J Infect Dis 1995 171: 489 93.
10. Hayes E, Talbot S, Matheson E, Pressler H, Hanna A, McCarthy C. Health status of pediatric refugees in Portland ME. Arch Pediatr Adolesc Med 1998 152: 564 8.
11. Walker P, Jaranson J. Refugee and immigrant health care. Med Clin North Am 1999 83: 1103 20.
12. Sinnerbrink I, Silove D, Manicavasagar V, Steel Z, Field A. Asylum seekers: general health status and problems with access to health care. Med J Aust 1996 165: 634 7.
13. Moreno A, Crosby S, Labelle, Sullivan M, Samet J. Health assessment of HIV-infected refugees. J Acquir Immune Defic Syndr 2003 34: 251 4.
14. Worth H, Denholm N, Bannister J. HIV/AIDS and the African Refugee education program in New Zealand. AIDS Educ Prev 2003 15: 346 56.
15. Bouree P, Lamour P, Bisaro F, Didier E. Etue d'une population d'origine tropicale, VIH positive, dans un centre de refugies en France. Bull Soc Pathol Exot 1995 88: 24 8.
16. Zhou J, Kumarasamy Z, Ditanco R, Kamarulzaman A, Lee C, Li P et al. The TREAT Asia HIV observational database: baseline and retrospective data. J Acquir Immune Defic Syndr 2005 38: 174 9.
17. Thomas M, Ellis-Pegler R. Tuberculosis in those with HIV infection. NZ Med J 1997 110: 352 4.
18. Staszewski S, Morales-Ramirez J, Tashima K, Rachlis A, Skiest D, Stanford J et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. N Engl J Med 1999 341: 1865 73.
19. Phillips A, Staszewski S, Weber R, Kirk O, Ftancioli P, Miller V et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA 2001 286: 2560 67.